Efficacy and safety of Percutaneous Collagen Induction by Needles in the treatment of Frontal Fibrosing Alopecia

Hospital Universitário Walter Cantídeo Universidade Federal do Ceará0 个研究点开始时间: 2020年9月28日最近更新: 2023年5月29日

试验速览

暂无简介。

•Patients with clinical diagnosis of Frontal fibrosing alopecia will be selected, including those with increased frontotemporal recess, associated or not with follicular papules and rarefaction of eyebrows; or histopathological diagnosis compatible with frontal fibrosing alopecia with follow up appointments at the Dermatology Department of Walter Cantideo University Hospital. Patients must be aged between 18 and 70 years old and must sign who the Informed Consent Form (ICF), with availability to attend periodic appointment evaluations.

•Patients with the following conditions will be excluded: Pregnancy; Vitiligo, psoriasis or other skin diseases that present Koebner's phenomenon (development of chronic dermatosis in trauma areas); Active infections in the areas to be treated with microneedling; Presence of keloids in previous scars; History of allergy to topical or injectable anesthetic; Patients with psychiatric disorders or other clinical diseases that contraindicate the procedure; Patients who refuse to sign the Informed Consent Form (ICF) or who are unable to attend to periodic appointment evaluations.

发起方

Hospital Universitário Walter Cantídeo Universidade Federal do Ceará